Yahoo Web Search

Search results

    • Q1 2024 Panbela Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 24 minutes ago

      Despite this approval, which was based on the median overall survival benefit of 1.9 months compared to gemcitabine and nab-paclitaxel, the prognosis for patients with metastatic pancreatic ...